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A case history of the induction of asthma and chemical sensitivity in a 42-year-old registered nurse
illustrates several of the characteristic features of multiple chemical sensitivity (MCS). This patient's
problems started shortly after moving into a new home under construction, with associated
chemical exposures. Other MCS patients report the onset of the condition with other chemical
exposures such as those encountered at their places of work or use of pesticides at their
residences. Patients often describe a spreading phenomenon of increasing intolerance to commonly
encountered chemicals at concentrations well tolerated by other people. Symptoms usually wax
and wane with exposures, and are more likely to occur in patients or families with preexisting
histories of migraine or with classical allergies. Idiosyncratic medication reactions (especially to
preservative chemicals) are common in MCS patients, as are dysautonomia symptoms (such as
vascular instability) and poor temperature regulation. Myalgia and joint pains and food intolerance
are common features as well. Contamination with xenobiotic chemicals is frequently found in these
patients when they are tested. Reactive airways dysfunction syndrome is a recently identified
condition that exhibits features of both asthma and chemical sensitivity. MCS patients frequently
have patterns of neurotoxic brain metabolism that can be confirmed on single photo emission
computed tomography imaging. Environ Health Perspect 105(Suppl 2):437-441 (1997)
Key words: allergy, asthma, brpnchospasm, hypersensitivity, multiple chemical sensitivity,
reactive airways dysfunction syndrome, solvent exposure
Introduction
The characteristic clinical features ofchemi-
cal sensitivity, which includes such factors
as demographic data, frequency of symp-
toms, and theories of pathogenesis, have
been described by several authors (1-8).
However, an illustrative case presentation
that demonstrates many of the features of
chemical sensitivity can put such demo-
graphic and epidemiological data into a
useful clinical setting. The case that follows
exhibits many ofthe characteristic features
ofthe clinical course ofchemical sensitivity.
A Case History
PresentingProblems
Mrs. M.V. was a 42-year-old registered
nurse who, when first seen by the author,
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had been an inpatient in a tertiary care
hospital from May until November 1991.
She had been diagnosed with intractable
asthma and laryngeal stridor, and was
receiving continuous intravenous infusion
ofepinephrine through a subclavian central
venous line. Ingestion ofany food or con-
tact with many commonly encountered
chemical odors triggered laryngeal stridor
and increased wheezing. These symptoms
could only be controlled with the iv epi-
nephrine and pushes of Benadryl (Parke-
Davis, Morris Plains, NJ) and occasionally,
Solu-Cortef(Upjohn, Kalamazoo, MI).
HistoryofPresentingIllness
The nurse's presenting history listed her as
last being in reasonably good health in the
spring of 1976. A year before she had a left
first rib resection for a thoracic outlet syn-
drome and recovered very well. Shortly
after the surgery, however, she moved with
her family into an unfinished cedar home,
where they lived while construction con-
tinued. As the interior construction pro-
ceeded, she was exposed to dust, fumes,
paint, varnish, unfinished plywood floors,
primers, carpeting, sheet rock, and many
other construction glues and chemicals.
She reported no significant symptoms or
intolerance ofthese exposures at that time.
Two months after the start of this
exposure, she had the right first rib resec-
tion, and immediately after the surgery she
experienced a postoperative hemorrhage. A
mediastinal hematoma caused a tracheal
shift, and she had the onset of asthma for
the first time. She was given iv amino-
phylline and Solu-Cortef, which helped to
control her bronchospasm. However, 3 hr
later, significant stridor began. When she
was given more steroids in an effort to con-
trol these symptoms, she developed a psy-
chosis and the picture of an organic brain
syndrome. As the patient continued to
recover from the surgery, she developed a
recurring pattern of bronchospasm with
wheezing, stridor, and tracheal infections.
This progressed to intolerance of many
medications and other products, especially
those containing preservatives like benzyl
alcohol, which induced severe asthma.
Over the next few months, the patient
reported that many different kinds ofchemi-
cal exposures triggered irritability, weakness,
severe stridor, wheezing, and respiratory
distress. Such chemical hypersensitivity had
not been noted previously.
The nurse continued to experience
increasing chemical reactivityand symptoms
began to appear on exposure to a wide vari-
ety ofcommon chemicals in concentrations
found in everyday settings that were well
tolerated by other individuals. The symp-
toms waxed and waned with exposures. She
often reacted with bronchospasm or stridor
to the undetected presence of chemicals
(e.g., propane gas for cooking in a restau-
rant), or she detected and reported chemical
odors long before other people became
aware ofthem. The major effects of these
exposures were bronchial hypersensitivity,
wheezing, stridor, and dysphonia, all of
which could be triggered on exposures to
chemical substances such as perfume, phe-
nol, disinfectants, wintergreen, new carpet-
ing, natural gas, formaldehyde, lipsticks, and
many others. The patient developed a pat-
tern ofintractable and severe wheezing. The
only therapeutic intervention that consis-
tently controlled her symptoms was iv infu-
sion ofepinephrine. After bronchospasm
was induced, she was often in the hospital
forweeks or months.
PastHealth
The nurse's past health was marked by a
2-month cough in 1963 that a physician
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thought was an allergic reaction. In 1979,
approximately 4 years after the induction of
the asthma and stridor, skin-prick testing
was performed by an allergist to determine
the extent and severity of allergies that
might be triggering wheezing and stridor.
When given a desensitization treatment
injection containing a phenol preservative,
the patient developed severe asthma, went
into shock, and was hospitalized for a
week. When the treatment solution was
diluted by a factor of 10, and injections
restarted at one lower concentration, the
third therapeutic injection in the new series
resulted in a hospital admission for 2 weeks
with similar symptoms.
In 1979, the patient was referred to a
nationally known clinic where skin testing
was again attempted; this induced signifi-
cant bronchospasm and respiratory distress.
The patient was treated with iv steroids,
after which she again became very agitated
and irrational. During this time she was told
that her problems were mostly psychiatric
and that she was neurotic. On one occasion
during an episode ofsignificant laryngeal
irritation and stridor, the patient was asked
to bend over, upon which she lost con-
sciousness, became cyanotic, and had to
have a face maskapplied. In 1981 she devel-
oped right-sided hyperesthesia and for
2 weeks, slight rotary nystagmus. She was
diagnosed with possible multiple sclerosis,
although the symptoms later disappeared. In
1982 she experienced severe stridor induced
by benzyl alcohol preservative in a heparin
lock flush being used in a central venous
line. The patient went on to develop a
pattern of recurrent laryngeal infections,
especially in the spring and fall, usually
attributable to Hemophilus influenza. These
infections almost invariably progressed to
significant bronchospasm, wheezing, and
stridor, resulting in hospitalization for 3 to
4 weeks at a time. At this time she was
placed on Rifampin on a full-time basis as
prophylaxis for these infections.
Systems Review
On systems review, some of the patient's
key problems were that of easy bruising,
migraine headaches, especially when she
took birth control pills, indigestion with
bloating and flatulence from ingestion of
certain foods, cold hands and feet, arthritic-
like knee and other joint pains, recurrent
vaginal yeast infections, difficulty ofswal-
lowing in the presence of the stridor, con-
firmed hypoglycemia, abdominal pain with
the ingestion ofsulfite-containing foods,
and significant wheezing and stridor upon
ingesting monosodium glutamate. Smoke
from burning wood, which was very preva-
lent in the area where she lived, always
induced wheezing.
Social andFamilyHistory
The patient, a registered nurse, when first
evaluated had been disabled for 10 years
because of persistent life-threatening
asthma and widespread chemical sensitivi-
ties. She was married and had two children.
She had no history ofpsychiatric medica-
tions or admissions. Her family history
revealed that her mother had lifelong
eczema and was troubled with arthritis and
head stuffiness. Her father died ofrespira-
tory failure and had lead poisoning from
working with lead-based paints, while
painting railway cars. She had five brothers,
the oldest ofwhom had asthma, and his
children had asthma. A sister's children also
had asthma. A son has asthma and food
allergies, and a daughter has asthma and
food allergies and was on desensitization
shots. The patient's medications at the time
of initial evaluation were epinephrine iv
infusion, Solu-Cortef (approximately once
per month), iv Benadryl (25-50 mg every
3-4 hr as needed for allergic symptoms),
Rifampin, oral sodium cromolyn, Seldane,
Tagamet, and Pulmicort.
Environmental History
The patient's pertinent environmental
history revealed she was living in a cedar
home that frequently was pervaded by the
aromatic smell ofwood terpene. The home
was insulated with fiberglass and was pur-
posely built to be tight and energy effi-
cient. There was a deep artesian well. Weed
control herbicides were used yearly on the
lawn, and insecticide powder was used in
the basement. Mold grew around the win-
dows, where water condensation frequently
occurred. The bedroom in which she slept
had unfinished plywood floors.
Physical Exam
The physical exam revealed vital signs of
temperature 97.8, pulse 80, respiration 16,
and blood pressure 110/60. The patient had
evidence ofpharyngitis and allergidike rhini-
tis; she had 11 silver amalgam fillings in
her teeth. There was no wheezing when she
was initially examined while receiving an iv
drip ofepinephrine. Otherwise, the physical
examination appearedwithin normal limits.
L-boratoryInvestigation
Results of a laboratory investigation ofthe
possibility ofchemical contamination are
Table 1. Blood xenobiotic contaminants.
Laboratory
Chemical Value, ppb mean, ppb
Toluene 5.2 2.1
Trimethylbenzenes 1.4 <1.0
1,1,1-Trichloroethane 1.1 <1.0
2-Methylpentane 20.7 9.6
3-Methylpentane 48.0 17.4
n-Hexane 17.7 8.3
Data from Ashley et al. (9).
shown in Table 1. These analyses were per-
formed by AccuChem Labs (Richardson,
TX) using the gas chromatography-mass
spectroscopy methodology cited by the
Centers for Disease Control and Prevention
as the most accurate available (9). It should
be noted that the patient's level oftoluene,
for example, was 10 times less than the U.S.
population mean of 0.52 ppb (9). The
patient's serum IgE was 175 on a scale of
1 to 180.
Discussion
This patient's presentation illustrates
several features that are commonly seen
in chemicalIv sensitive patients. There
often is a preexisting or concurrent history
of allergic disease in the patient and/or
the patient's family. Similarly, a tendency
toward migraine or dysautonomia symp-
toms (e.g., cold hands and feet and diffi-
culty with temperature regulation) is
frequently present. This patient exhibited
the spreading phenomenon (2,3), whereby
she became increasingly sensitive to awider
and wider variety ofstructurally unrelated
chemical substances once the process of
chemical sensitivity was initiated.
Mrs. M.V. also had two frequently
reported initiating factors that have been
described by chemically sensitive patients as
triggering events in the induction of their
problems (1). Figure 1 shows the results of
a survey of200 chemically sensitive patients
at the Environmental Health Center-
Dallas, Dallas, Texas. The most frequently
reported trigger was a newly constructed
home or ajob sitewhere occupants orwork-
ers were extensively exposed to construction
materials such as paints, solvents, carpet,
etc. These types of new home or job site
renovations account for 30% ofthe triggers
of MCS cited by 200 patients at the
Environmental Health Center-Dallas
(Figure 1). Other types ofchemical expo-
sures (e.g., pesticides) account for another
24%. Miller and Mitzel (10) reported on
groups ofchemically sensitive patients who
cited remodeling or pesticide applications
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Figure 1. Suspected triggers of MCS in 200 chemically
sensitive patients in studies conducted at the
Environmental Health Center-Dallas, Dallas, Texas.
Abbreviations: chem, chemicals; O.R., operation with
anesthesia; MVA, motorvehicle accident.
as initiating events. While their symptoma-
tology was similar, the pesticide-exposed
group reported more severe symptoms, as
would be expected because of the greater
neurotoxicity ofthat group ofchemicals. It
was felt that this finding provided evidence
for a possible biological basis for chemical
sensitivity, with a common pathophysiolog-
ical induction pathway of MCS between
these two groups ofexposed patients.
The patient in this case also was admin-
istered anesthetic during surgery and
experienced a postoperative hemorrhage.
Surgeries with anesthetics are cited as trig-
gers of MCS by 7% of 200 MCS patients
(Figure 1). It has been the experience ofthe
author that the induction ofa vasculitislike
syndrome with blood vessel fragility and
easy bleeding is commonly seen in chemi-
cally exposed patients, whether or not they
report chemical sensitivity (11-13).
Mrs. M.V. also exhibited thejoint pains
and food intolerances with gas and bloating
so often seen in chemically sensitive patients
(1). Vasospastic phenomena and dysau-
tonomia are also frequently noted in these
patients (14,15) and these symptoms corre-
late with the vasospastic phenomena seen in
odor- and food-induced migraine (16). It is
ofinterest that the patient had a psychotic
and agitated response to steroids, which is
similar to the neurocognitive or emotional
instability reported by MCS patients at
times in response to chemical exposures.
Some authors have ascribed such symptoms
in chemically sensitive patients to psychi-
atric diagnoses (17-19), but the validity
of these conclusions has been seriously
questioned in a recent critical review (5).
Moreover, an animal model has been recog-
nized that can explain many ofthe features
ofsuch an illness on a physiological basis of
time-dependent sensitization and limbic
kindling or other neurological sensitization
(7,20-23). Bell and colleagues have
reported a role for organic factors contri-
buting to the poor health in patients with
cacosmia, one ofthe features characterizing
chemical sensitivity (24). In our experience,
the incidence ofsignificant psychiatric dis-
ease as a major causative factor in MCS is
verylow, probably less than 2 or 3%.
Findings ofneurotoxic patterns on cere-
bral metabolism after chemical exposures
(25) lend credence to the organic origin of
the neurocognitive complaints of poor
memory and concentration frequently
reported by MCS patients. Callender has
shown the effectiveness ofbrain metabolic
single photo emission-computed tomogra-
phy scans in following the objective chronic
central nervous system effects subsequent to
an acute insecticide exposure (26); Simon
has found evidence for neurotoxic effects on
cerebral metabolism in chemically exposed
and chemically sensitive patients (27).
Legitimate criticisms can be raised
about the validity and reproducibility of
these scans and about whether the behav-
ioral state ofthe patient will influence the
results (28). Simon and colleagues make
use ofa strictly standardized protocol, men-
tal status evaluation, and visual imagery
during this procedure (29).
Finally, this patient had substantial
chemical contamination with xenobiotics
at levels that were significantly higher than
the mean from the reference laboratory.
Indeed, her blood levels of toluene and
1,1,1-trichloroethane, for example, were
well above the 95th percentile when com-
pared to values found in nonoccupationally
exposed persons in the United States using
the same methodology (9). Chemical cont-
amination is an important issue, and one
that generates disagreement and different
points ofview. Critics argue that the levels
ofpotentially toxic xenobiotics found in
many patients who claim chemical sensitiv-
ity are meaningless and thus not clinically
relevant from a toxicological point ofview
(30). Others contend that these substances
are foreign to the body and that the ordi-
nary dose-response curve assumptions may
not apply for low levels ofthese toxic xeno-
biotics. Indeed, there is evidence that low
levels of mixtures of genotoxic chemicals
(including benzene) may actually be more
damaging than higher levels because they
do not trigger an appropriate induction of
detoxification enzymes (31). In addition,
there is evidence that the synergistic effect
of multiple low levels ofpotentially toxic
xenobiotics may be clinically relevant,
as appears to be the case in chemically
exposed GulfWarveterans (32). This find-
ing is consistent with the fact that many
chemically sensitive, chemically contami-
nated patients appear to have impaired
detoxification abilities (33,34).
The patient had symptoms that waxed
and waned on exposure; these symptoms
were much more likely to occur ifshe also
developed an infection. This illustrates the
principle of the total load, which can be
applied to all patients (3). Once the total
load exceeds a certain threshold, a patient's
adaptive mechanisms seem no longer capa-
ble of maintaining homeostasis (3,35).
This patient later developed a pattern of
bronchospasm induced by chemical expo-
sures that might be classified as reactive
airways dysfunction syndrome (36,37).
Treatment
At the request of Mrs. M.V.'s attending
consultant, she was air transported 2500
miles, escorted by a physician, to the
Environmental Control Unit at Tri-City
Hospital in Dallas. This specialized hospital
wing is constructed ofless polluting con-
struction materials and has a highly filtered
air system. Organically grown food, bottled
water, and specialized procedures are
employed to minimize indoor airpollutants.
This creates a safe environment for the sta-
bilization, investigation, and treatment of
chemically sensitive patients (38,39).
Within 36 hr of entering the filtered
atmosphere of this unit, the patient's
wheezing resolved and all her medications
were stopped. She fasted for 4 days, drank
only bottled spring water, and then started
on a monorotational diet of organically
grown foods. Some foods were found to
trigger her wheezing and stridor, whereas
others did not.
The patient was found to be extremely
sensitive to the sulfite preservative in epi-
nephrine, which was confirmed byintrader-
mal testing. Pure, sulfite-free epinephrine
was obtained and was used either iv or by sc
injection to abort her bronchospasm and
wheezing with excellent results. Previously,
if these symptoms were induced, the
patient knew by experience that she would
wheeze and be in distress for weeks to
months at a time.
A comprehensive treatment program
was developed (40) that included avoiding
chemical triggers, eating a rotational diet
oforganically grown foods, administration
of immunotherapy antig.ens to reduce
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the extent and severity of allergies and
sensitivities, environmental cleanup at home
(using less toxic materials), and specific
nutritional support to enhance detoxifica-
tion ability to supply antioxidant nutrients.
The patient made significant improve-
ment on this regimen. After 10 years of
disability, she was able to resume her nurs-
ing career, and over the next 3 years she
remained much more stabilized. She con-
tinued to exhibit chemical sensitivity,
including episodes ofwheezing and stridor
triggered by certain exposures, but these
could usually be aborted by a single injec-
tion or two of sc pure epinephrine. Anti-
histamines, bronchodilators, and steroids
were almost useless in this patient's case.
Over the next 3 years, she had only a few
briefhospital stays, whereas previously she
had been in the hospital for weeks or
months at a time.
Some recent outcome studies (41-44)
have shown evidence ofthe efficacy ofsuch
comprehensive treatment programs for
polysymptomatic patients who report
chemical sensitivity. Maberly and col-
leagues have found positive results in the
treatment of asthma in the controlled
atmosphere and surroundings of the
Environmental Control Unit, clearly
demonstrating the adverse effect ofcertain
foods and chemicals on the peak flow rate
(41). They also found successful and signif-
icant reduction ofsymptoms and medica-
tion use after treatment involving dietary
modification and subcutaneous immuno-
therapy antigens to alleviate complex
allergy and sensitivities (42).
Maberly and colleagues also cited
evidence ofbeneficial outcomes in poly-
symptomatic patients using a comprehen-
sive environmental medicine approach
(43) including the types of interventions
discussed in this case history.
Maberly's experience parallels the
improvement in symptoms reported by
chemically sensitive and polysympto-
matic patients treated at the Nova Scotia
Environmental Medicine Clinic in Halifax,
Canada, a government-sponsored project.
In an uncontrolled study of85 patients
reporting chemical sensitivity symptoms,
scores were followed by the Nova Scotia
Department of Health over 10 months of
treatment. In addition to assessing the level
of patient satisfaction with the services
provided, symptom changes were carefully
evaluated using pre- and posttreatment
questionnaires. There were statistically sig-
nificant improvements in the scores for a
number ofsymptoms using comprehensive
environmental medicine treatment; these
included scores for mental confusion,
fatigue, headache, and anxiety (44).
The limitations ofsuch unblinded and
uncontrolled global outcome measure-
ments are obvious. Nevertheless, such
information provides a starting point from
which to ask more definitive questions.
This pilot clinic has now been superseded
by the Nova Scotia Environmental Health
Clinic, a medical school-based research and
treatment program that is also funded by
the government ofNova Scotia. It is hoped
that more answers will be forthcoming
from well designed clinical trials currently
planned and underway.
Although this case presentation involves
consideration of classic allergic symptoms
in addition to symptoms ofMCS, it also
illustrates several key features of chemical
sensitivity and some of the intervention
and treatment approaches that can be very
helpful for these patients.
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